Bright Minds Biosciences Inc
Officers & Directors
Ian McDonald, age 38, serves as President, Chief Executive Officer, and Director. He has experience as an entrepreneur and former investment banker, with a background in management of TSX-listed gold mining companies, Canadian investment banking, and private equity. Ryan Cheung, age 47, is Chief Financial Officer and founder and managing partner of MCPA Services Inc., Chartered Professional Accountants. He has experience auditing junior venture and resource companies and holds degrees in accounting and commerce. Stephen D. Collins, age 73, is Chief Medical Officer. He previously served as CEO of Biscayne Neurotherapeutics and Biscayne Pharmaceuticals and held leadership roles at Neurotherapeutics Pharma and Ovation Pharmaceuticals, which was acquired by Lundbeck A/S.
Bright Minds Biosciences Inc currently has 57 employees.
News about Bright Minds Biosciences Inc Key Personnel |
Bright Minds Biosciences: A $35 Million Gamble Amidst Dismal Financials and Industry CompetitionIn an audacious move that has raised eyebrows among investors and market analysts alike, Bright Minds Biosciences Inc. (CSE: DRUG) (NASDAQ: DRUG) has closed a non-brokered private placement, securing $35 million by selling 1,612,902 common shares at a price of $21.70 each. The announcement, made on November 4, 2024, marks a significant financial maneuver for the Vancouver-based biotech company, especially considering its recent performance and the fiercely competitive landscape it faces.This considerable influx of cash comes on the heels of the company reporting a cumulative net loss of $6 million during the 12 mo...
|
|
